NEW YORK, NY / ACCESSWIRE / October 18, 2019 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:
Ra Pharmaceuticals, Inc. (NASDAQ:RARX)
The investigation concerns whether Ra Pharmaceuticals and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Ra Pharmaceuticals to UCB S.A. for $48.00 per share. If you are a Ra Pharmaceuticals shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/ra-pharmaceuticals-inc-rarx-stock-merger-ucb/.
Dova Pharmaceuticals, Inc. (NASDAQ:DOVA)
The investigation concerns whether Dova and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Dova to Swedish Orphan Biovitrum AB. Under the terms of the agreement, Dova shareholders will be offered an upfront payment for $27.50 per share in cash and one non-tradeable Contingent Value Right to an additional $1.50 per share in cash upon regulatory approval of DOPTELET. If you are a Dova shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/dova-pharmaceuticals-inc-sobi-stock-merger-swedish/.
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN)
The investigation concerns whether Achillion and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Achillion to Alexion Pharmaceuticals, Inc. If you are an Achillion shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/achillion-pharmaceuticals-inc-alexion-stock-merger/.
On behalf of shareholders of these companies, Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.
Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com
SOURCE: Halper Sadeh LLP
View source version on accesswire.com:
https://www.accesswire.com/563477/SHAREHOLDER-INVESTIGATION-ALERT-Halper-Sadeh-LLP-Continues-To-Investigate-Whether-The-Sale-Of-These-Companies-Is-Fair-To-Shareholders--RARX-DOVA-ACHN
